Most recently, it's been discovered that conolidine and the above derivatives act within the atypical chemokine receptor three (ACKR3. Expressed in similar areas as classical opioid receptors, it binds to a wide array of endogenous opioids. In contrast to most opioid receptors, this receptor functions to be a scavenger https://robertn109yab9.bloguerosa.com/profile